Beam Therapeutics Inc. - 8-K Filing
Beam Therapeutics held its annual stockholder meeting on June 3, 2026, where three proposals were voted upon. The election of directors resulted in the following votes for Class III nominees: John Evans received 71,684,417 'for' votes (95.8%), John Maraganore Ph.D. received 64,846,080 'for' votes (89.3%), and Christi Shaw received 65,652,959 'for' votes (89.9%). Deloitte & Touche LLP was ratified as the independent auditor with 85,754,272 'for' votes (98.1%). The advisory vote on executive compensation had 71,546,749 'for' votes (90.3%). (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $BEAM